BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 30185599)

  • 1. Persistent Replication of HIV, Hepatitis C Virus (HCV), and HBV Results in Distinct Gene Expression Profiles by Human NK Cells.
    Boeijen LL; Hou J; de Groen RA; Verbon A; Boonstra A
    J Virol; 2019 May; 93(9):. PubMed ID: 30185599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HBsAg stimulates NKG2D receptor expression on natural killer cells and inhibits hepatitis C virus replication.
    Wang XX; Pan XB; Han JC; Cong X; Jin Q; Kong XS; Wei L; Feng B
    Hepatobiliary Pancreat Dis Int; 2018 Jun; 17(3):233-240. PubMed ID: 29625837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA 130a Regulates both Hepatitis C Virus and Hepatitis B Virus Replication through a Central Metabolic Pathway.
    Duan X; Li S; Holmes JA; Tu Z; Li Y; Cai D; Liu X; Li W; Yang C; Jiao B; Schaefer EA; Fusco DN; Salloum S; Chen L; Lin W; Chung RT
    J Virol; 2018 Apr; 92(7):. PubMed ID: 29321333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating CD56dim natural killer cells and CD56+ T cells that produce interferon-γ or interleukin-10 are expanded in asymptomatic, E antigen-negative patients with persistent hepatitis B virus infection.
    Conroy MJ; Mac Nicholas R; Grealy R; Taylor M; Otegbayo JA; O'Dea S; Mulcahy F; Ryan T; Norris S; Doherty DG
    J Viral Hepat; 2015 Mar; 22(3):335-45. PubMed ID: 25186004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B virus and hepatitis C virus infection among HIV-1-infected injection drug users in Dali, China: prevalence and infection status in a cross-sectional study.
    Dong Y; Qiu C; Xia X; Wang J; Zhang H; Zhang X; Xu J
    Arch Virol; 2015 Apr; 160(4):929-36. PubMed ID: 25616842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HCV viraemia associates with NK cell activation and dysfunction in antiretroviral therapy-treated HIV/HCV-co-infected subjects.
    Papasavvas E; Azzoni L; Yin X; Liu Q; Joseph J; Mackiewicz A; Ross B; Lynn KM; Jacobson JM; Mounzer K; Kostman JR; Montaner LJ
    J Viral Hepat; 2017 Oct; 24(10):865-876. PubMed ID: 28419653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD3(+)CD56(+) Natural Killer-Like T Cells Display Anti-HCV Activity but Are Functionally Impaired in HIV(+) Patients With Acute Hepatitis C.
    Kokordelis P; Krämer B; Boesecke C; Voigt E; Ingiliz P; Glässner A; Wolter F; Srassburg CP; Spengler U; Rockstroh JK; Nattermann J
    J Acquir Immune Defic Syndr; 2015 Dec; 70(4):338-46. PubMed ID: 26509931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel cell culture model reveals the viral interference during hepatitis B and C virus coinfection.
    Zhang K; Lai X; Song J; He L; Wang L; Ou G; Tian X; Wang L; Deng J; Zhang J; Li C; Zhuang H; Li T; Xiang K
    Antiviral Res; 2021 May; 189():105061. PubMed ID: 33705864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between hepatitis B viremia and the clinical and histological activity of chronic delta hepatitis.
    Lozano JL; Crespo J; de la Cruz F; Casafont F; Lopez-Arias MJ; Martín-Ramos L; Pons-Romero F
    Med Microbiol Immunol; 1994 Jul; 183(3):159-67. PubMed ID: 7997189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological changes in different patient populations with chronic hepatitis C virus infection.
    Szereday L; Meggyes M; Halasz M; Szekeres-Bartho J; Par A; Par G
    World J Gastroenterol; 2016 May; 22(20):4848-59. PubMed ID: 27239111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An effective interferon-gamma-mediated inhibition of hepatitis C virus replication by natural killer cells is associated with spontaneous clearance of acute hepatitis C in human immunodeficiency virus-positive patients.
    Kokordelis P; Krämer B; Körner C; Boesecke C; Voigt E; Ingiliz P; Glässner A; Eisenhardt M; Wolter F; Kaczmarek D; Nischalke HD; Rockstroh JK; Spengler U; Nattermann J
    Hepatology; 2014 Mar; 59(3):814-27. PubMed ID: 24382664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation and altered function of natural killer cells in hepatitis B virus patients treated with entecavir.
    Zhao PW; Jia FY; Shan YX; Ji HF; Feng JY; Niu JQ; Ayana DA; Jiang YF
    Clin Exp Pharmacol Physiol; 2013 Mar; 40(3):190-6. PubMed ID: 23278368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contradicting roles of miR-182 in both NK cells and their host target hepatocytes in HCV.
    El Sobky SA; El-Ekiaby NM; Mekky RY; Elemam NM; Mohey Eldin MA; El-Sayed M; Esmat G; Abdelaziz AI
    Immunol Lett; 2016 Jan; 169():52-60. PubMed ID: 26518141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon-alpha-induced TRAIL on natural killer cells is associated with control of hepatitis C virus infection.
    Stegmann KA; Björkström NK; Veber H; Ciesek S; Riese P; Wiegand J; Hadem J; Suneetha PV; Jaroszewicz J; Wang C; Schlaphoff V; Fytili P; Cornberg M; Manns MP; Geffers R; Pietschmann T; Guzmán CA; Ljunggren HG; Wedemeyer H
    Gastroenterology; 2010 May; 138(5):1885-97. PubMed ID: 20334827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of hepatitis B, C, and D viruses in dual and triple infection: influence of viral genotypes and hepatitis B precore and basal core promoter mutations on viral replicative interference.
    Jardi R; Rodriguez F; Buti M; Costa X; Cotrina M; Galimany R; Esteban R; Guardia J
    Hepatology; 2001 Aug; 34(2):404-10. PubMed ID: 11481626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KIR2DL3⁺NKG2A⁻ natural killer cells are associated with protection from productive hepatitis C virus infection in people who inject drugs.
    Thoens C; Berger C; Trippler M; Siemann H; Lutterbeck M; Broering R; Schlaak J; Heinemann FM; Heinold A; Nattermann J; Scherbaum N; Alter G; Timm J
    J Hepatol; 2014 Sep; 61(3):475-81. PubMed ID: 24780303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal evaluation of viral interactions in treated HIV-hepatitis B co-infected patients with additional hepatitis C and D virus.
    Boyd A; Lacombe K; Miailhes P; Gozlan J; Bonnard P; Molina JM; Lascoux-Combe C; Serfaty L; Gault E; Desvarieux M; Girard PM
    J Viral Hepat; 2010 Jan; 17(1):65-76. PubMed ID: 19682317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Replication Inhibition of Hepatitis B Virus and Hepatitis C Virus in Co-Infected Patients in Chinese Population.
    Yu G; Chi X; Wu R; Wang X; Gao X; Kong F; Feng X; Gao Y; Huang X; Jin J; Qi Y; Tu Z; Sun B; Zhong J; Pan Y; Niu J
    PLoS One; 2015; 10(9):e0139015. PubMed ID: 26422607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Profile of patients triply infected with HIV and the hepatitis B and C viruses in the HAART era.
    Maida I; Ríos MJ; Pérez-Saleme L; Ramos B; Soriano V; Pegram PS; Mura MS; Sánchez-Margalet V; Saldívar-Cornejo I; Wilkin A; Babudieri S; Núñez M
    AIDS Res Hum Retroviruses; 2008 May; 24(5):679-83. PubMed ID: 18462085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ethnic differences in viral dominance patterns in patients with hepatitis B virus and hepatitis C virus dual infection.
    Nguyen LH; Ko S; Wong SS; Tran PS; Trinh HN; Garcia RT; Ahmed A; Lutchman GA; Keeffe EB; Nguyen MH
    Hepatology; 2011 Jun; 53(6):1839-45. PubMed ID: 21425314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.